JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aminobutyrates", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antihypertensive Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Combinations", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heart Failure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neprilysin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Stroke Volume", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tetrazoles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Valsartan", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Preventive Cardiology and Rehabilitation Unit, DSB 29 \u201cS.\u00a0Gennaro dei Poveri Hospital\u201d, via S.Gennaro dei Poveri 25, 80136, Napoli, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Preventive Cardiology and Rehabilitation Unit, DSB 29 \u201cS.\u00a0Gennaro dei Poveri Hospital\u201d, via S.Gennaro dei Poveri 25, 80136, Napoli, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "De Vecchis", 
        "givenName": "R.", 
        "id": "sg:person.0704361014.79", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0704361014.79"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Geriatrics, Casa di Cura \u201cSollievo della Sofferenza\u201d, viale Cappuccini\u00a02, 71013, San Giovanni Rotondo, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Preventive Cardiology and Rehabilitation Unit, DSB 29 \u201cS.\u00a0Gennaro dei Poveri Hospital\u201d, via S.Gennaro dei Poveri 25, 80136, Napoli, Italy", 
            "Division of Geriatrics, Casa di Cura \u201cSollievo della Sofferenza\u201d, viale Cappuccini\u00a02, 71013, San Giovanni Rotondo, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ariano", 
        "givenName": "C.", 
        "id": "sg:person.0660263343.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660263343.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Geriatrics, Clinic \u201cS. Maria del Pozzo\u201d, via Pomigliano\u00a040, 80049, Somma Vesuviana, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Division of Geriatrics, Clinic \u201cS. Maria del Pozzo\u201d, via Pomigliano\u00a040, 80049, Somma Vesuviana, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Di Biase", 
        "givenName": "G.", 
        "id": "sg:person.01066703417.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01066703417.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Mid-German Heart Center, Department of Internal Medicine III, Division of Cardiology, Angiology and Intensive Medical Care, University Hospital Halle, Martin-Luther-University Halle, Ernst Grube-Stra\u00dfe\u00a040, 06120, Halle, Germany", 
          "id": "http://www.grid.ac/institutes/grid.9018.0", 
          "name": [
            "Mid-German Heart Center, Department of Internal Medicine III, Division of Cardiology, Angiology and Intensive Medical Care, University Hospital Halle, Martin-Luther-University Halle, Ernst Grube-Stra\u00dfe\u00a040, 06120, Halle, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Noutsias", 
        "givenName": "M.", 
        "id": "sg:person.01077606445.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01077606445.25"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s11897-017-0327-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084033357", 
          "https://doi.org/10.1007/s11897-017-0327-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00059-017-4626-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091896405", 
          "https://doi.org/10.1007/s00059-017-4626-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00059-013-3772-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047353802", 
          "https://doi.org/10.1007/s00059-013-3772-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/164_2016_77", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000389269", 
          "https://doi.org/10.1007/164_2016_77"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-01-19", 
    "datePublishedReg": "2018-01-19", 
    "description": "BackgroundThe combination drug sacubitril/valsartan was reported to be superior to enalapril in reducing all-cause death, cardiovascular mortality, and heart failure (HF) hospitalizations in patients with cardiac insufficiency and reduced left ventricular ejection fraction (HFREF) with NYHA class\u00a0II\u2013IV.MethodsOur retrospective cohort study aimed to assess the effects of sacubitril/valsartan in addition to a\u00a0beta-blocker and mineral receptor antagonist (MRA) in a\u00a0group of HFREF patients with NYHA class\u00a0II\u2013III HF vs. conventional therapy (ACE inhibitor or angiotensin\u00a0II receptor blocker added to a beta-blocker plus an\u00a0MRA) administered to a\u00a0control group of HFREF patients with comparable clinical features. In both groups, treatment was supplemented by a\u00a0loop diuretic, usually furosemide, at variable doses. The primary outcomes were all-cause death and HF hospitalizations. Safety outcomes were symptomatic hypotension, angioedema, hyperkalemia, and worsening renal function.ResultsMortality at 6\u00a0months was 6.8% in patients taking sacubitril/valsartan vs. 34% in those on conventional therapy (odds ratio [OR]\u00a0= 0.14; 95% CI: 0.04\u20130.49). Moreover, there was a 4.5% rate of HF hospitalizations in the sacubitril/valsartan group vs. 59% in the control group (OR\u00a0= 0.03; 95% CI: 0.01\u20130.14). Safety outcomes were comparable in the two groups, although hypotension (systolic blood pressure <\u202f100\u2009mm\u00a0Hg) was found in 15.9% of patients in the sacubitril/valsartan group vs. 5.7% in the control group (OR\u00a0= 3.14; 95% CI: 0.94\u201310.55).ConclusionSacubitril/valsartan offered strong protection against all-cause death and HF hospitalizations at 6\u00a0months without any significant side effects. To validate this efficacious molecule, further postmarketing observational studies, focusing mainly on hypotension and angioedema are warranted.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00059-017-4671-1", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1087175", 
        "issn": [
          "0340-9937", 
          "1615-6692"
        ], 
        "name": "Herz", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "44"
      }
    ], 
    "keywords": [
      "sacubitril/valsartan", 
      "sacubitril/valsartan group", 
      "left ventricular ejection fraction", 
      "ventricular ejection fraction", 
      "HF hospitalization", 
      "control group", 
      "HFrEF patients", 
      "cause death", 
      "NYHA class", 
      "valsartan group", 
      "ejection fraction", 
      "conventional therapy", 
      "safety outcomes", 
      "reduced left ventricular ejection fraction", 
      "heart failure hospitalization", 
      "retrospective cohort study", 
      "comparable clinical features", 
      "significant side effects", 
      "symptomatic hypotension", 
      "renal function", 
      "cardiovascular mortality", 
      "cohort study", 
      "primary outcome", 
      "heart failure", 
      "clinical features", 
      "cardiac insufficiency", 
      "loop diuretics", 
      "receptor antagonist", 
      "observational study", 
      "side effects", 
      "hospitalization", 
      "patients", 
      "variable doses", 
      "hypotension", 
      "valsartan", 
      "efficacious molecules", 
      "angioedema", 
      "death", 
      "therapy", 
      "outcomes", 
      "months", 
      "group", 
      "ResultsMortality", 
      "enalapril", 
      "diuretics", 
      "hyperkalemia", 
      "strong protection", 
      "insufficiency", 
      "antagonist", 
      "mortality", 
      "doses", 
      "treatment", 
      "study", 
      "effect", 
      "failure", 
      "fraction", 
      "rate", 
      "protection", 
      "function", 
      "addition", 
      "features", 
      "HF", 
      "molecules", 
      "class", 
      "combination drug sacubitril/valsartan", 
      "drug sacubitril/valsartan", 
      "failure (HF) hospitalizations", 
      "MethodsOur retrospective cohort study", 
      "mineral receptor antagonist", 
      "ConclusionSacubitril/valsartan"
    ], 
    "name": "Sacubitril/valsartan for heart failure with reduced left ventricular ejection fraction", 
    "pagination": "425-432", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1100478773"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00059-017-4671-1"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29350254"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00059-017-4671-1", 
      "https://app.dimensions.ai/details/publication/pub.1100478773"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:48", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_773.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00059-017-4671-1"
  }
]

Download the RDF metadata as:  json-ld nt turtle xml License info

This table displays all metadata directly associated to this object as RDF triples.

224 TRIPLES      22 PREDICATES      112 URIs      100 LITERALS      19 BLANK NODES